Corcept Therapeutics Incorporated (CORT) Ownership

$88.15

north_east
$2.67 (3.12%)
Day's range
$85.8
Day's range
$88.69

Corcept Therapeutics Incorporated Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 12.05 M $1.00 B   -3.85% 11.57%
VANGUARD GROUP INC 11/07/2025 9.54 M $792.63 M   -1.48% 9.16%
INGALLS & SNYDER LLC 11/07/2025 7.70 M $639.78 M   -0.32% 7.39%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 6.09 M $506.09 M   -2.83% 5.85%
PARALLEL ADVISORS, LLC 11/13/2025 3.87 M $321.76 M   0.01% 3.72%
STATE STREET CORP 11/14/2025 2.97 M $246.87 M   0.09% 2.85%
FMR LLC 11/13/2025 2.20 M $183.00 M   62.27% 2.12%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.93 M $161.53 M   0.97% 1.86%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 1.89 M $157.28 M   -9.26% 1.82%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 1.51 M $125.26 M   546.89% 1.45%
MORGAN STANLEY 11/14/2025 1.19 M $98.65 M   -26.46% 1.14%
CLEARBRIDGE INVESTMENTS, LLC 11/13/2025 1.16 M $96.56 M   -0.52% 1.12%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 1.07 M $88.95 M   31.41% 1.03%
TD ASSET MANAGEMENT INC 11/10/2025 956.14 K $79.46 M   16.62% 0.92%
JPMORGAN CHASE & CO 11/26/2025 849.86 K $70.63 M   223.37% 0.82%
EPOCH INVESTMENT PARTNERS, INC. 11/13/2025 847.10 K $70.40 M   10.67% 0.81%
CERITY PARTNERS LLC 10/22/2025 758.43 K $63.03 M   1.58% 0.73%
INVESCO LTD. 11/13/2025 732.58 K $60.88 M   -29.00% 0.70%
FIRST TRUST ADVISORS LP 11/12/2025 720.22 K $59.86 M   34.07% 0.69%
NORTHERN TRUST CORP 11/14/2025 642.33 K $53.38 M   -1.53% 0.62%
BANK OF NEW YORK MELLON CORP 11/03/2025 601.50 K $49.99 M   -5.83% 0.58%
D. E. SHAW & CO., INC. 11/14/2025 584.10 K $48.54 M   -13.23% 0.56%
BOSTON TRUST WALDEN CORP 10/17/2025 562.26 K $46.73 M   -1.72% 0.54%
UBS GROUP AG 11/13/2025 549.94 K $45.71 M   413.77% 0.53%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2025 526.60 K $43.77 M   9.41% 0.51%
PRINCIPAL FINANCIAL GROUP INC 11/04/2025 521.50 K $43.34 M   -2.61% 0.50%
SYNERGY ASSET MANAGEMENT, LLC 10/21/2025 506.86 K $39.61 M   96.08% 0.49%
FRANKLIN RESOURCES INC 11/13/2025 500.06 K $41.56 M   2.19% 0.48%
CHECKPOINT CAPITAL L.P. 11/14/2025 392.33 K $32.61 M   14.08% 0.38%
PACER ADVISORS, INC. 10/15/2025 390.56 K $32.46 M   6,796.68% 0.38%
GOLDMAN SACHS GROUP INC 11/14/2025 389.09 K $32.34 M   -30.60% 0.37%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 383.06 K $31.84 M   160.42% 0.37%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 369.87 K $30.74 M   16.31% 0.36%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 369.39 K $30.70 M   -53.17% 0.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 11/06/2025 365.84 K $30.40 M   13.70% 0.35%
JUPITER ASSET MANAGEMENT LTD 11/10/2025 350.93 K $29.17 M   -41.65% 0.34%
FAS WEALTH PARTNERS, INC. 10/29/2025 308.32 K $25.62 M   1.95% 0.30%
BRIDGEWATER ASSOCIATES, LP 11/13/2025 305.95 K $25.43 M   100.00% 0.29%
LEGAL & GENERAL GROUP PLC 11/13/2025 286.80 K $23.84 M   -4.02% 0.28%
BRAUN STACEY ASSOCIATES INC 10/21/2025 280.66 K $23.33 M   -2.29% 0.27%
ABRDN PLC 11/07/2025 259.08 K $21.53 M   -7.00% 0.25%
BROWN CAPITAL MANAGEMENT LLC 11/04/2025 240.05 K $19.95 M   100.00% 0.23%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 10/20/2025 239.81 K $20.20 M   11.75% 0.23%
EMERALD ADVISERS, LLC 10/30/2025 232.45 K $19.32 M   -3.97% 0.22%
BURNEY CO/ 10/16/2025 230.77 K $19.18 M   -7.75% 0.22%
AMERIPRISE FINANCIAL INC 11/14/2025 222.38 K $18.48 M   -46.95% 0.21%
COOKSON PEIRCE & CO INC 11/06/2025 211.31 K $17.56 M   -2.81% 0.20%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 202.73 K $16.85 M   -38.68% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 201.00 K $16.71 M   10.38% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 188.70 K $15.68 M   -12.31% 0.18%

Corcept Therapeutics Incorporated institutional Ownership - FAQ's

During the previous two years, 578 institutional investors and hedge funds held shares of Corcept Therapeutics Incorporated. The most heavily invested institutionals were:

BlackRock, Inc.: 12.05 M

VANGUARD GROUP INC: 9.54 M

INGALLS & SNYDER LLC: 7.7 M

RENAISSANCE TECHNOLOGIES LLC: 6.09 M

Parallel Advisors, LLC: 3.87 M

STATE STREET CORP: 2.97 M

74.15% of Corcept Therapeutics Incorporated stock is owned by institutional investors.

Institutional investors have bought a total of 105.92 M shares in the last 24 months. This purchase volume represents approximately $9.34 B in transactions.